Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...
Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
Where there's a will, there are funds to deal with urban challengesProjects worth ₹15,000 crore across six states are being awarded to kick-start the Centre's ₹1 lakh crore Urban Challenge Fund. These initi...
HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
Tata group’s Impetis out-licenses arthritis and autoimmune drugs to VyomeIn a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...
US market today: Biotech firm Odyssey hits nearly $900 million valuation as shares rise in Nasdaq debutOdyssey Therapeutics debuted on Nasdaq with an 11.1% surge, reaching a $899.9 million valuation. The autoimmune disease specialist successf...
US stocks today: Space analytics firm HawkEye 360 valued at $3.15 billion after NYSE debutHawkEye 360's stock surged 30% on its Thursday debut, reaching a $3.15 billion valuation after raising $416 million in its U.S. IPO. The de...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
‘I am in debt, struggling but free’: 24-year-old woman fled from home to Calicut, dreams of finding her mom and working at Swiss Parliament somedayA 24-year-old woman from Calicut found freedom after escaping years of abuse and fear. She now lives independently, facing financial strugg...
Christina Applegate’s health struggle: Rising concern as friends brace for the 'worst' after latest medical reportApplegate has been candid about her diagnosis and how it has affected her life. Since publicly confirming her condition in August 2021, she...
'Who are you?' he asked his wife before his daughter's wedding. CT scan, MRI reports normal. Neurologist points out the real culpritA 60-year-old father's memory loss and behavioral changes during his daughter's wedding were initially blamed on stress. Medical tests were...
Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
After her dad's death, she took care of everyone and built a career. But at 23, she lost her life to 'simple fever'. What happened?Priyanshi Mehta achieved significant career success at a young age, supporting her family after her father's death. She moved to Mumbai for...
What is Autoimmune Encephalitis? The rare brain disease that forced Aussie athlete Tiana Death to relearn how to walk, talk and writeTiana Death, a former Australian athletics champion, has revealed her diagnosis of autoimmune encephalitis, a rare neurological condition. ...
Glenmark's subsidiary Ichnos Sciences enters pact with Almirall for novel drug to treat autoimmune diseasesUnder the agreement, Almirall is granted global rights to develop and commercialize this monoclonal antibody for autoimmune diseases. Ichno...
Hairloss, severe mouth ulcers, skin rashes? Get yourself checked for autoimmune diseasesAutoimmune disorders is when the immune system turns against healthy cells, and affect more women than men.